SITC Cancer Immunotherapy CONNECT

Winter School

Early Registration for Cancer Immunotherapy Winter School Closing Soon

Register by Dec. 12 and save up to $200 off regular rates. Through this hybrid program attendees will experience the best in cancer immunotherapy education taught by leading experts in the field.

Register Today

SITC 2022 Logo.png

Thank you for joining over 7,400 immuno-oncology experts at SITC 2022.
Join your colleagues at SITC 2023 in San Diego, CA from Nov. 1-5. Save the date!

Spring Scientific logo.png

Get Ready for the SITC Spring Scientific

Please join us for our SITC Spring Scientific, Host Immunity in Immunotherapy Responses: From Discoveries to Precision Oncology on March 15–17, 2023 in Denver, CO. Attend in person or virtually!

REGISTER NOW  SUBMIT AN ABSTRACT

Call for Proposals

Call for Proposals

SITC is holding an open call for proposals! SITC leadership wants to hear ideas from its members, which will inspire content for future workshops, webinars, consensus meetings and manuscripts.

SUBMIT A PROPOSAL

SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.

Download Now

Target for Cancer IO.png

SITC’s Value Framework for Phase III Immuno-Oncology Trials 

Announcing the publication of the manuscript, "Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer".


READ MANUSCRIPT

New SITC Clinical Practice Guidelines Published

Includes Acute Leukemia, Breast Cancer, Hepatocellular Carcinoma, Immune Checkpoint Inhibitor-related Adverse Events, Urothelial Cancer, & Nonmelanoma Skin Cancer. Free companion educational webinars available.

Learn more

Target for Cancer IO.png

Targets for Cancer IO: A Deep Dive Series

This highly anticipated series addresses key cancer IO questions in depth, and with top faculty leading the discussion. Register soon! Special offer available.

LEARN MORE

JITC Anniversary

Celebrate a Decade of Publishing with SITC’s Official Journal

Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.

LET'S CELEBRATE!

icon-patients.png

For patients

Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them.

Explore

icon-stethoscope.png

For Clinicians

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.


Explore

icon-researcher.png

For Researchers

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.


Explore

Latest Discussions

  • Post-doctoral Fellow - Cancer immunology, immunotherapy Surgery Branch, National Cancer Institute, NIH NAME OF HIRING OFFICIAL/INVESTIGATOR Steven A. Rosenberg, M.D., Ph.D. Job Description Seeking a Post-Doctoral Fellow for ...

  • Surgery Branch/Cancer Immunotherapy Research Fellowships are available at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under the leadership of Dr. Steven A. Rosenberg. These fellowships are open to US categorical general ...

  • Date & Location Saturday, December 3, 2022, 8:00 AM - 4:30 PM, MD Anderson - Main Building, Hickey Auditorium (R11.1400), Houston, TX The Zoom ID and Password will be communicated via email 72 hours before the symposium start time. Credits ...

icon-twitter.png

Follow the SITC Twitter Feed.

Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking toadvance research in the cancer immunotherapy field.

Learn More

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More